Liberty Health Sciences announced it upgraded its US stock to the OTCQX Best Market, under the symbol LHSIF.
“Qualifying to trade on OTCQX Best Market represents an important and exciting milestone for our company as we continue our targeted U.S. expansion,” said George Scorsis, CEO and Director of Liberty. “We’re committed to offering our growing U.S. investor base an industry leading trading experience and this step helps achieve that goal.”
Liberty was sponsored for OTCQX by Sichenzia Ross Ference Kesner LLP, a qualified third-party firm responsible for providing guidance on OTCQX requirements and recommending membership.
“OTCQX companies are distinguished by their commitment to providing a superior trading and information experience for their investors. We look forward to supporting Liberty Health Sciences in the public market,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group Inc.